78 results
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
or agent or other representative of a party, including any investigation by any Governmental Entity.
“Trademarks” has the meaning set forth in “Intellectual … , investigation or proceeding pending before any Governmental Entity and, to the Knowledge of the Seller, no such action, claim, suit, investigation
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
Change (but, for the avoidance of doubt, Borrower has not undertaken any investigation of or made any inquiries to, or relating to, any of its or its … , criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, warning letter, untitled letter, proceeding
8-K
EX-2.1
eskynr6zx
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
sdx9k
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
ls4lcmc8yd
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
yqry28k3j z9e080
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
4sy92rqejr10fxlvl6v0
16 Jun 23
Business combination disclosure
8:08am
425
w5t47kj9l ku680byk5
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
c5u2na bdj0j9
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
5hpzoqrik1 nuxo1
18 May 23
Other Events
5:02pm